Clinical Trials on Platinum-resistant Recurrent Ovarian Cancer in New Zealand
Total 0 results
Nothing found
Sponsors and Collaborators
- Polak David
- Spital Linth
- NewGenPharm Inc.
- Jason Lang, M.D., M.P.H.
- Wuxi Second People's Hospital
- Hospital Dr. Gustavo Fricke
- Kai Lin Xu; Jun Nian Zheng
- Apoyo Positivo
- Neurological Rehabilitation Hospital Rosenhügel
- Beckman Coulter GmbH
- EDOP Society
- Komazawa University
- Binawaluya Cardiac Hospital, Jakarta
- Rudolf Foundation Clinic
- Monir Hussein Bahgat, Faculty of Medicine, Mansura University
- Hellenic Society of Hematology
- Bangladesh Rural Advancement Committee
- BLUECOMPANION LTD
- Children's Cancer Research Fund
- Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
- View Full List
Medical Conditions
- Diabetic Cardiovascular Autonomic Neuropathy (DCAN)
- Macular Ischemia
- Medication Related Osteonecrosis of the Jaw
- Drug Transporter
- Neonates and Preterm Infants
- The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease
- Breast Feeding, Exclusive
- Chronic Cough Caused by Gastroesophageal Reflux
- Inhalation of Nitrous Oxide
- Catecholaminergi Polymorphic Ventricular Tachycardia
- Drug Compliance
- Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
- Childhood Malignant Tumors of Lower Limbs
- Lumbar Discogenic Pain
- Composition of Gut Microbiota
- Implementation Science
- Neovascular Polypoidal Choroidal Vasculopathy
- GM1 Gangliosidoses
- Non-Erosive Gastro-Esophageal Reflux Disease
- Antibody Response After Vaccination
- View Full List
Drug Interventions
- K-877 0.1 mg tablet
- MK0557
- PEP005 Topical Gel
- Myocet
- Aerosolized Buccal Midazolam
- 140/100 μg Azelastine hydrochloride/Beclomethasone Dipropionate)
- Lamivudine 150-mg tablet single dose (drug test)
- Bupivacaine standard dose
- IDP 120 Component B Gel
- T3: Test Product O
- Lipid-lowering agents (Artovastatin)
- HXe MRI lung ventilation
- Didanosine, ddI (drug)
- Imatinib
- LIPO-102
- Trastuzumab Emtansine
- Cisplatin
- DM-CHOC-PEN
- Sequential therapy for 14 days
- Anastrozole 1mg
- View Full List
CROs by country
- Contract Research Organizations in Brazil
- Contract Research Organizations in China
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Estonia
- Contract Research Organizations in Iran
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Philippines
- Contract Research Organizations in Sweden
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Tanzania
- CRO list by country